Takeshita Shigeru, Moritani Maki, Kunika Kiyoshi, Inoue Hiroshi, Itakura Mitsuo
Department of Diabetes, Pharmacology Research Laboratories, Astellas Pharma Inc., Ibaraki, Japan.
Mamm Genome. 2006 Sep;17(9):927-40. doi: 10.1007/s00335-005-0130-z. Epub 2006 Sep 8.
To identify novel genetic modifiers of type 2 diabetes (T2D), we performed quantitative trait loci (QTL) analysis on F(2) progeny of hypoinsulinemic diabetic Akita mice, heterozygous for the Ins2 gene Cys96Tyr mutation, and nondiabetic A/J mice. We generated 625 heterozygous (F(2)-Hetero) and 338 wild-type (F(2)-Wild) mice with regard to the Ins2 mutation in F(2) intercross progeny. We measured quantitative traits, including plasma glucose and insulin concentrations during the intraperitoneal glucose tolerance test (IPGTT), and body weight (BW). We observed three significant QTLs in hypoinsulinemic hyperglycemic male F(2)-Hetero mice, designated Dbm1, Dbm3, and Dbm4 on Chromosomes 6, 14, and 15, respectively. They showed linkage to plasma glucose concentrations, with significant maximum logarithm of odds (LOD) scores of 4.12, 4.17, and 6.17, respectively, all exceeding threshold values by permutation tests. In normoinsulinemic normoglycemic male F(2)-Wild mice, Dbm1 on Chromosome 6 showed linkage to both plasma insulin concentrations and BW, and Dbm2 on Chromosome 11 showed linkage to plasma glucose concentrations only, with LOD scores of 4.52 and 6.32, and 5.78, respectively. Based on these results, we concluded that Dbm1, Dbm2, Dbm3, and Dbm4 represent four major modifier QTLs specifically affecting T2D-related traits and that these diabetic modifier QTLs are conditional on the heterozygous Ins2 gene mutation and sex to exert their modifier functions. Identification of the genes responsible for these QTLs would provide new drug development targets for human T2D.
为了鉴定2型糖尿病(T2D)的新型遗传修饰因子,我们对低胰岛素血症糖尿病秋田小鼠(Ins2基因Cys96Tyr突变的杂合子)与非糖尿病A/J小鼠的F2代后代进行了数量性状基因座(QTL)分析。我们在F2代杂交后代中产生了625只关于Ins2突变的杂合子(F2-杂合子)小鼠和338只野生型(F2-野生型)小鼠。我们测量了数量性状,包括腹腔内葡萄糖耐量试验(IPGTT)期间的血浆葡萄糖和胰岛素浓度,以及体重(BW)。我们在低胰岛素血症高血糖雄性F2-杂合子小鼠中观察到三个显著的QTL,分别位于6号、14号和15号染色体上,命名为Dbm1、Dbm3和Dbm4。它们与血浆葡萄糖浓度连锁,通过置换检验,最大对数优势(LOD)分数分别为4.12、4.17和6.17,均超过阈值。在正常胰岛素血症正常血糖雄性F2-野生型小鼠中,6号染色体上的Dbm1与血浆胰岛素浓度和BW均连锁,11号染色体上的Dbm2仅与血浆葡萄糖浓度连锁,LOD分数分别为4.52、6.32和5.78。基于这些结果,我们得出结论,Dbm1、Dbm2、Dbm3和Dbm代表四个主要的修饰QTL,特异性影响与T2D相关的性状,并且这些糖尿病修饰QTL取决于杂合Ins2基因突变和性别来发挥其修饰功能。鉴定负责这些QTL的基因将为人类T2D提供新的药物开发靶点。